Skip to main content
logo
Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
81.60
-1.86 (-2.23%)
Apr 28, 2026, 12:02 PM EDT - Market open

Edwards Lifesciences Revenue by Segment

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Transcatheter Aortic Valve Replacement
4.49B4.36B4.24B4.14B4.11B4.05B3.99B3.94B
Transcatheter Aortic Valve Replacement Growth
9.29%7.77%6.28%5.20%5.83%7.46%8.65%9.90%
Surgical Structural Heard
1.03B1.02B1.00B999.60M1.01B1.02B1.03B1.02B
Surgical Structural Heard Growth
1.43%0.15%-2.25%-1.73%1.55%4.45%8.11%10.51%
Transcatheter Mitral and Tricuspid Therapies
550.60M500.00M445.90M394.40M352.10M303.00M264.30M228.90M
Transcatheter Mitral and Tricuspid Therapies Growth
56.38%65.02%68.71%72.30%78.19%75.04%75.73%75.13%
Critical Care
-------957.50M
Critical Care Growth
-------10.72%

Revenue by Geography

Period EndingDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Europe
1.52B1.45B1.38B1.34B1.37B1.37B1.37B1.37B
Europe Growth
11.02%6.10%0.94%-2.21%2.43%6.85%11.59%14.76%
United States
907.00M907.50M889.70M838.90M812.90M804.60M816.80M940.70M
United States Growth
11.58%12.79%8.93%-10.82%-9.11%-7.51%-8.77%10.79%
Rest of World
652.30M630.10M611.10M588.20M616.90M656.40M688.10M722.80M
Rest of World Growth
5.74%-4.01%-11.19%-18.62%-13.01%-3.09%5.05%16.28%
Japan
354.70M353.10M344.40M336.50M365.50M391.60M418.60M449.10M
Japan Growth
-2.95%-9.83%-17.73%-25.07%-19.21%-13.27%-6.40%-0.69%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.